We participated in a COST event on Action sustainability to discuss the opportunities for the future of our project. A summary report is available here.
February 15, 2024, Brussels, Belgium.
Gaye Hafez, from Turkey, participated in the ECNP Congress held in Milan, Italy, from September 21-24, 2024. She presented an e-poster titled “Antibacterial agents with
Authors: Carsten A Wagner, Ziad A Massy, Giovambattista Capasso, Francesco Mattace-Raso, Marion Pepin, Mickaël Bobot, Carmine Zoccali, Ana C Ferreira, Ewout J Hoorn, Pedro H
Authors: Davide Bolignano, Mariadelina Simeoni, Gaye Hafez, Marion Pepin, Antonio Gallo, Manuela Altieri, Sophie Liabeuf, Konstantinos Giannakou, Ananya De, Giovambattista Capasso, CONNECT Action (Cognitive Decline
COST is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation.
CONNECT aims to coordinate research on cognitive impairment in CKD. This requires exchanging clinical information between nephrologists and neurologists, and between neuroscientists and kidney physiologists, guided by big data analysts.
The COST Action CONNECT welcomes research-active scientists working in the field. According to COST rules, you can join CONNECT action.
